Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma
Crossref DOI link: https://doi.org/10.1186/s12885-017-3332-3
Published Online: 2017-05-22
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lisenko, K.
Dingeldein, G.
Cremer, M.
Kriegsmann, M.
Ho, A. D.
Rieger, M.
Witzens-Harig, M.